Back
Day Range
$202.00
$206.30
52-Week Range
$118.73
$218.00
Volume
279,177
50D / 200D Avg
$196.18
/
$174.81
Prev Close
$200.08
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 34.2 | 0.4 |
| P/B | 5.3 | 2.9 |
| ROE % | 16.9 | 3.8 |
| Net Margin % | 6.8 | 3.9 |
| Rev Growth 5Y % | 17.8 | 10.0 |
| D/E | 1.9 | 0.2 |
Analyst Price Target
Hold
$222.33
+9.8%
Low: $215.00
High: $230.00
Forward P/E
26.9
Forward EPS
$7.52
EPS Growth (est.)
+0.0%
Est. Revenue
5.8 B
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2028 |
$8.98
$8.89 – $9.07
|
6.9 B | 2 |
| FY2027 |
$8.24
$8.00 – $8.47
|
6.3 B | 3 |
| FY2026 |
$7.52
$7.51 – $7.57
|
5.8 B | 3 |
Key Takeaways
Revenue grew 17.79% annually over 5 years — strong growth
Earnings grew 15.44% over the past year
ROE of 16.91% — decent returns on equity
Generating 370.71M in free cash flow
P/E of 34.20 — premium valuation
Cash machine — converts 107.77% of earnings into free cash flow
Growth
Revenue Growth (5Y)
17.79%
Revenue (1Y)18.72%
Earnings (1Y)15.44%
FCF Growth (3Y)17.07%
Quality
Return on Equity
16.91%
ROIC5.09%
Net Margin6.80%
Op. Margin8.58%
Safety
Debt / Equity
1.86
Current Ratio1.42
Interest Coverage54.31
Valuation
P/E Ratio
34.20
P/B Ratio5.27
EV/EBITDA35.53
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 18.72% | Revenue Growth (3Y) | 16.46% |
| Earnings Growth (1Y) | 15.44% | Earnings Growth (3Y) | 28.17% |
| Revenue Growth (5Y) | 17.79% | Earnings Growth (5Y) | 15.30% |
| Profitability | |||
| Revenue (TTM) | 5.06B | Net Income (TTM) | 343.97M |
| ROE | 16.91% | ROA | 6.30% |
| Gross Margin | 13.74% | Operating Margin | 8.58% |
| Net Margin | 6.80% | Free Cash Flow (TTM) | 370.71M |
| ROIC | 5.09% | FCF Growth (3Y) | 17.07% |
| Safety | |||
| Debt / Equity | 1.86 | Current Ratio | 1.42 |
| Interest Coverage | 54.31 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 34.20 | P/B Ratio | 5.27 |
| P/S Ratio | 2.33 | PEG Ratio | 2.06 |
| EV/EBITDA | 35.53 | Dividend Yield | 0.00% |
| Market Cap | 11.76B | Enterprise Value | 15.41B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 5.06B | 4.26B | 3.73B | 3.03B | 2.63B |
| Net Income | 343.97M | 297.97M | 209.40M | 224.68M | 194.65M |
| EPS (Diluted) | 5.84 | 5.12 | 3.65 | 3.95 | 3.42 |
| Gross Profit | 695.13M | 667.59M | 590.76M | 517.99M | 468.21M |
| Operating Income | 433.80M | 358.30M | 255.37M | 296.83M | 260.47M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 5.46B | 4.67B | 4.18B | 3.45B | 2.85B |
| Total Liabilities | 3.23B | 2.83B | 2.68B | 2.20B | 1.83B |
| Shareholders' Equity | 2.23B | 1.84B | 1.49B | 1.25B | 1.02B |
| Total Debt | 4.15B | 1.97B | 1.87B | 1.57B | 1.27B |
| Cash & Equivalents | 503.88M | 464.60M | 509.63M | 316.27M | 262.20M |
| Current Assets | 1.27B | 1.16B | 1.05B | 781.13M | 639.71M |
| Current Liabilities | 894.35M | 743.43M | 734.75M | 582.07M | 523.07M |